|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
119,920,000 |
Market
Cap: |
2.20(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$14.96 - $32.96 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
136,870 |
194,989 |
260,525 |
524,601 |
Total Sell Value |
$2,679,704 |
$3,814,194 |
$5,546,549 |
$13,449,119 |
Total People Sold |
5 |
5 |
5 |
6 |
Total Sell Transactions |
10 |
19 |
38 |
75 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schuth Alexander O. |
COO and Secretary |
|
2021-03-04 |
4 |
AS |
$60.89 |
$610,171 |
I/I |
(10,000) |
531,582 |
|
9% |
|
Sato Vicki L |
Director |
|
2021-03-03 |
4 |
AS |
$60.36 |
$102,641 |
D/D |
(1,666) |
139,087 |
|
9% |
|
Watts Ryan J. |
President and CEO |
|
2021-03-01 |
4 |
AS |
$64.42 |
$1,216,551 |
I/I |
(18,334) |
2,305,742 |
|
12% |
|
Tessier-Lavigne Marc |
Director |
|
2021-03-01 |
4 |
AS |
$64.36 |
$6,622,207 |
D/D |
(100,000) |
2,642,296 |
|
12% |
|
Ho Carole |
Chief Medical Officer |
|
2021-03-01 |
4 |
AS |
$64.54 |
$470,741 |
I/I |
(7,092) |
165,141 |
|
12% |
|
Krognes Steve E. |
CFO and Treasurer |
|
2021-02-16 |
4 |
AS |
$64.27 |
$3,254,710 |
I/I |
(50,000) |
900,000 |
|
18% |
|
Crestline Management, Lp |
10% Owner |
|
2021-02-12 |
4 |
S |
$65.00 |
$144,091,870 |
I/I |
(2,216,798) |
9,984,836 |
|
-9% |
|
Ho Carole |
Chief Medical Officer |
|
2021-02-11 |
4 |
S |
$70.17 |
$221,972 |
I/I |
(3,156) |
172,233 |
|
-2% |
|
Watts Ryan J. |
President and CEO |
|
2021-02-11 |
4 |
S |
$70.17 |
$665,984 |
I/I |
(9,473) |
2,324,076 |
|
-2% |
|
Krognes Steve E. |
CFO and Treasurer |
|
2021-02-11 |
4 |
S |
$70.17 |
$213,480 |
D/D |
(3,035) |
97,587 |
|
-2% |
|
Schuth Alexander O. |
COO and Secretary |
|
2021-02-11 |
4 |
S |
$70.17 |
$214,341 |
I/I |
(3,047) |
541,582 |
|
-2% |
|
Krognes Steve E. |
CFO and Treasurer |
|
2021-02-09 |
4 |
S |
$74.38 |
$108,135 |
D/D |
(1,448) |
12,979 |
|
0% |
|
Schuth Alexander O. |
COO and Secretary |
|
2021-02-09 |
4 |
S |
$74.66 |
$109,809 |
I/I |
(1,468) |
537,344 |
|
0% |
|
Ho Carole |
Chief Medical Officer |
|
2021-02-09 |
4 |
S |
$74.40 |
$109,785 |
I/I |
(1,470) |
167,921 |
|
0% |
|
Watts Ryan J. |
President and CEO |
|
2021-02-09 |
4 |
S |
$73.24 |
$377,211 |
I/I |
(5,112) |
2,313,853 |
|
0% |
|
Watts Ryan J. |
President and CEO |
|
2021-02-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
14,316 |
2,318,965 |
|
- |
|
Krognes Steve E. |
CFO and Treasurer |
|
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,250 |
14,427 |
|
- |
|
Schuth Alexander O. |
COO and Secretary |
|
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
538,812 |
|
- |
|
Ho Carole |
Chief Medical Officer |
|
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
169,391 |
|
- |
|
Schuth Alexander O. |
COO and Secretary |
|
2021-02-04 |
4 |
AS |
$66.65 |
$678,361 |
I/I |
(10,000) |
534,562 |
|
6% |
|
Watts Ryan J. |
President and CEO |
|
2021-02-01 |
4 |
AS |
$68.21 |
$1,254,819 |
I/I |
(18,334) |
2,304,649 |
|
8% |
|
Krognes Steve E. |
CFO and Treasurer |
|
2021-01-15 |
4 |
AS |
$70.10 |
$3,572,556 |
I/I |
(50,000) |
950,000 |
|
-10% |
|
Watts Ryan J. |
President and CEO |
|
2021-01-04 |
4 |
AS |
$65.21 |
$6,621,782 |
I/I |
(88,334) |
2,322,978 |
|
-27% |
|
Schuth Alexander O. |
COO and Secretary |
|
2021-01-04 |
4 |
AS |
$65.17 |
$5,246,408 |
I/I |
(70,000) |
544,562 |
|
-27% |
|
Bratton Capital Inc. |
10% Owner |
|
2020-12-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(383,411) |
0 |
|
- |
|
416 Records found
|
|
Page 9 of 17 |
|
|